Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 ...

Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI  BioSpace

Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing - ...

Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing  Business Wire

How Meiji Seika Pharma Aims to Lead Global Health With New Vaccines and Antibiotics - The Worldfolio

How Meiji Seika Pharma Aims to Lead Global Health With New Vaccines and Antibiotics  The Worldfolio

Meiji Seika Pharma launches first-in-human trial of Novel PD-1 agonist for autoimmune diseases - ...

Meiji Seika Pharma launches first-in-human trial of Novel PD-1 agonist for autoimmune diseases  Indian Pharma Post

Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the...

Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis  Yahoo Finance

Japan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery ...

Japan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery  BioSpectrum Asia

Accord BioPharma Launches Biosimilar Ustekinumab in US - Pearce IP

Accord BioPharma Launches Biosimilar Ustekinumab in US  Pearce IP

Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery - ...

Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery  PharmiWeb.com

Meiji Seika Pharma Expands Global Reach with Breakthroughs in Antibiotics, Vaccines and Emerging ...

Meiji Seika Pharma Expands Global Reach with Breakthroughs in Antibiotics, Vaccines and Emerging Markets  The Worldfolio

Meiji to establish Singapore subsidiary to expand biz in ASEAN region - BioSpectrum Asia

Meiji to establish Singapore subsidiary to expand biz in ASEAN region  BioSpectrum Asia

Osivax secures strategic funding from Meiji Seika - The Pharma Letter

Osivax secures strategic funding from Meiji Seika  The Pharma Letter

Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims - The Japan Times

Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims  The Japan Times

Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy - Business Wire

Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy  Business Wire

Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary "Taiwan Meiji Pharma Co...

Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary "Taiwan Meiji Pharma Co., Ltd." in Taiwan  BioSpace

Meiji Seika Pharma: Adcock Ingram Pharma Private Limited Completes Construction of a New Manufact...

Meiji Seika Pharma: Adcock Ingram Pharma Private Limited Completes Construction of a New Manufacturing Facility in India to Enhance its CMO Business  Business Wire

Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovati...

Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovative Drugs and Technologies  Business Wire

Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance ...

Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance Its CMO Business  Business Wire

Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidate...

Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidates  Business Wire

Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan - BioSpectrum...

Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan  BioSpectrum Asia

Meiji Seika Pharma Sets up a New Subsidiary in the US - Business Wire

Meiji Seika Pharma Sets up a New Subsidiary in the US  Business Wire

Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility - Co...

Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility  Contract Pharma

Japan's Meiji Seika to build $20.1M manufacturing plant in India - Fierce Pharma

Japan's Meiji Seika to build $20.1M manufacturing plant in India  Fierce Pharma

Japan's Meiji Seika Pharma expands CMO business in India - BioSpectrum Asia

Japan's Meiji Seika Pharma expands CMO business in India  BioSpectrum Asia

Drug company sues lawmaker over ‘bioweapon’ claim on vaccine - 朝日新聞

Drug company sues lawmaker over ‘bioweapon’ claim on vaccine  朝日新聞

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 s...

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan  Fierce Pharma

Fedora Pharmaceuticals and Meiji Seika Pharma Sign Basic - GlobeNewswire

Fedora Pharmaceuticals and Meiji Seika Pharma Sign Basic  GlobeNewswire

Meiji Seika Pharma to build new facility in India for enhancing CMO biz - BioSpectrum Asia

Meiji Seika Pharma to build new facility in India for enhancing CMO biz  BioSpectrum Asia

Tradition to drive innovation - The Worldfolio

Tradition to drive innovation  The Worldfolio

Meiji Seika Pharma teams with lab to research hair loss cure - Nikkei Asia

Meiji Seika Pharma teams with lab to research hair loss cure  Nikkei Asia

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business - Indian Pharma Post

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business  Indian Pharma Post

Meiji Seika Pharma to launch two products from Santen Pharmaceutical Co., Ltd. in Indonesia - ANT...

Meiji Seika Pharma to launch two products from Santen Pharmaceutical Co., Ltd. in Indonesia  ANTARA News